BiTE (BCMA x CD3 Bispecific Antibody)

DRUG2 trials

Sponsors

West China Hospital, Turun Song

Conditions

Antibody Mediated Rejection After Kidney TransplantationHLA SensitizationKidney Transplantation Recipients

Phase 4

Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA ≥ 90%

Not yet recruitingNCT07689149

West China HospitalHLA Sensitization, Kidney Transplantation Recipients

Start: 2026-06-30End: 2029-12-31Target: 20Updated: 2026-07-08

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection

RecruitingNCT07689578

Turun SongAntibody Mediated Rejection After Kidney Transplantation

Start: 2026-07-30End: 2029-12-31Target: 50Updated: 2026-08-05